The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathological and clinical features of non-acral cutaneous melanoma (CM) patients (pts) with TP53 and BRAFNon-V600 (NonV600) mutations (muts).
 
Dae Won Kim
No Relationships to Disclose
 
Lauren Elaine Haydu
No Relationships to Disclose
 
Aron Joon
No Relationships to Disclose
 
Roland L. Bassett
No Relationships to Disclose
 
Alan Siroy
No Relationships to Disclose
 
Michael T. Tetzlaff
No Relationships to Disclose
 
Alexander Lazar
No Relationships to Disclose
 
Scott Eric Woodman
No Relationships to Disclose
 
Jeffrey E. Gershenwald
Consulting or Advisory Role - Castle Biosciences; Merck; Navidea
Patents, Royalties, Other Intellectual Property - mercator therapeutics
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)